A. K. Dadayan

487 total citations
35 papers, 375 citations indexed

About

A. K. Dadayan is a scholar working on Pharmaceutical Science, Spectroscopy and Molecular Biology. According to data from OpenAlex, A. K. Dadayan has authored 35 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmaceutical Science, 12 papers in Spectroscopy and 9 papers in Molecular Biology. Recurrent topics in A. K. Dadayan's work include Chemical Reactions and Isotopes (22 papers), Mass Spectrometry Techniques and Applications (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). A. K. Dadayan is often cited by papers focused on Chemical Reactions and Isotopes (22 papers), Mass Spectrometry Techniques and Applications (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). A. K. Dadayan collaborates with scholars based in Russia, United Kingdom and Tajikistan. A. K. Dadayan's co-authors include Yu. A. Zolotarev, N. F. Myasoedov, Yu. А. Borisov, O. Yu. Sokolov, Н. В. Кост, A. A. Zozulya, S. A. Grachev, Eduard V. Bocharov, Oleg Varlamov and Rustam Ziganshin and has published in prestigious journals such as Chemical Reviews, The Journal of Physical Chemistry C and Experimental Gerontology.

In The Last Decade

A. K. Dadayan

32 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. K. Dadayan Russia 10 179 113 69 53 45 35 375
Tomáš Elbert Czechia 11 195 1.1× 40 0.4× 98 1.4× 33 0.6× 16 0.4× 38 402
Elizabeth Drolle Canada 11 377 2.1× 22 0.2× 59 0.9× 18 0.3× 14 0.3× 21 613
Michal Bachar Israel 7 306 1.7× 36 0.3× 91 1.3× 20 0.4× 16 0.4× 8 466
Gerald J. Putterman United States 12 274 1.5× 51 0.5× 73 1.1× 10 0.2× 40 0.9× 23 625
Norihiro Shinkai Japan 15 198 1.1× 94 0.8× 124 1.8× 6 0.1× 14 0.3× 26 414
Shanmugarathinam Alagarsamy India 10 165 0.9× 41 0.4× 202 2.9× 7 0.1× 13 0.3× 26 413
Audrey Aebi Switzerland 6 76 0.4× 54 0.5× 66 1.0× 31 0.6× 6 0.1× 7 378
Annett Schroeter Germany 13 264 1.5× 268 2.4× 51 0.7× 10 0.2× 5 0.1× 17 489
F. Sundby Denmark 14 273 1.5× 15 0.1× 165 2.4× 29 0.5× 37 0.8× 21 638

Countries citing papers authored by A. K. Dadayan

Since Specialization
Citations

This map shows the geographic impact of A. K. Dadayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. K. Dadayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. K. Dadayan more than expected).

Fields of papers citing papers by A. K. Dadayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. K. Dadayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. K. Dadayan. The network helps show where A. K. Dadayan may publish in the future.

Co-authorship network of co-authors of A. K. Dadayan

This figure shows the co-authorship network connecting the top 25 collaborators of A. K. Dadayan. A scholar is included among the top collaborators of A. K. Dadayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. K. Dadayan. A. K. Dadayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zolotarev, Yu. A., О. В. Долотов, Dmitrii D. Markov, et al.. (2024). NEUROPROTECTIVE EFFECT OF HLDF-6-H PEPTIDE IN PARKINSON'S DISEASE.. 32–41.
3.
Zolotarev, Yu. A., Vladimir A. Mitkevich, С. И. Шрам, et al.. (2021). Pharmacokinetics and Molecular Modeling Indicate nAChRα4-Derived Peptide HAEE Goes through the Blood–Brain Barrier. Biomolecules. 11(6). 909–909. 9 indexed citations
4.
Sokolov, O. Yu., T. A. Prokhorova, Е. Б. Терешкина, et al.. (2021). Neurotropic peptide HLDF-6-amide reduces age-related decline in sexual activity in old male rats. Experimental Gerontology. 149. 111329–111329. 4 indexed citations
5.
Dadayan, A. K., Yu. А. Borisov, Yu. A. Zolotarev, et al.. (2021). Solid-State Catalytic Hydrogen/Deuterium Exchange in Mexidol. Russian Journal of Physical Chemistry A. 95(2). 273–278. 1 indexed citations
6.
Dadayan, A. K., Yu. А. Borisov, Yu. A. Zolotarev, & N. F. Myasoedov. (2021). Modeling Hydrogen Spillover on Oxide Catalytic Centers. Russian Journal of Physical Chemistry A. 95(5). 944–948. 2 indexed citations
7.
Zolotarev, Yu. A., et al.. (2019). Pharmacokinetics of HLDF-6-AA Peptide in the Organism of Experimental Animals. Russian Journal of Bioorganic Chemistry. 45(6). 514–521. 2 indexed citations
8.
Lopatin, Yu. M., et al.. (2018). Experimental evaluation of the effectiveness of local treatment of skin burns with сarbopol easier to disperse 2020 hydrogel with human leukemia differentiation factor-6 peptide. Bulletin of the Russian Military Medical Academy. 20(3). 148–152. 1 indexed citations
9.
Kopylov, Arthur T., N. F. Myasoedov, A. K. Dadayan, et al.. (2016). Use of deuterium labeling by high‐temperature solid‐state hydrogen‐exchange reaction for mass spectrometric analysis of bradykinin biotransformation. Rapid Communications in Mass Spectrometry. 30(11). 1283–1294. 7 indexed citations
10.
Zolotarev, Yu. A., Н. В. Кост, O. Yu. Sokolov, et al.. (2016). Anxiolytic activity of the neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB/c and C57BL/6 mice. Journal of Psychopharmacology. 30(9). 922–935. 11 indexed citations
11.
Zolotarev, Yu. A., A. K. Dadayan, Н. В. Кост, et al.. (2015). The qualitative analysis of the amide of the HLDF-6 peptide and its metabolites in tissues of laboratory animals with the use of tritium-labeled and deuterium-labeled derivatives. Russian Journal of Bioorganic Chemistry. 41(6). 578–589. 8 indexed citations
12.
Sokolov, O. Yu., Н. В. Кост, A. K. Dadayan, et al.. (2014). Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity. Peptides. 56. 68–71. 73 indexed citations
13.
Zolotarev, Yu. A., A. K. Dadayan, Eugene V. Gasanov, et al.. (2014). Solid phase isotope exchange of deuterium and tritium for hydrogen in human recombinant insulin. Russian Journal of Bioorganic Chemistry. 40(1). 26–35. 11 indexed citations
14.
Кост, Н. В., et al.. (2009). β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides. 30(10). 1854–1860. 76 indexed citations
15.
Zolotarev, Yu. A., О. В. Долотов, A. K. Dadayan, et al.. (2006). Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes. Amino Acids. 30(4). 403–408. 14 indexed citations
16.
Zolotarev, Yu. A., Yu. А. Borisov, A. K. Dadayan, & N. F. Myasoedov. (2006). Isotopic effects in the electronic spectra of tryptophan. Amino Acids. 31(4). 403–407. 5 indexed citations
17.
Zolotarev, Yu. A., A. K. Dadayan, & Yu. А. Borisov. (2005). Solid phase isotope exchange with spillover hydrogen in amino acids, peptides, and proteins. Russian Journal of Bioorganic Chemistry. 31(1). 1–17. 7 indexed citations
18.
Zolotarev, Yu. A., et al.. (2005). Isotopic effect of electron excitation in l-[3H]tryptophan. Journal of Molecular Structure THEOCHEM. 724(1-3). 53–59. 3 indexed citations
19.
Zolotarev, Yu. A., et al.. (2003). New development in the tritium labelling of peptides and proteins using solid catalytic isotopic exchange with spillover-tritium. Amino Acids. 24(3). 325–333. 51 indexed citations
20.
Zolotarev, Yu. A., A. K. Dadayan, Yu. А. Borisov, et al.. (2003). The effect of three-dimensional structure on the solid state isotope exchange of hydrogen in polypeptides with spillover hydrogen. Bioorganic Chemistry. 31(6). 453–463. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026